Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,204 results
- RE-PACTIndependent statistical analysis of Respiratory Exacerbation Plans for Action and Care Transitions for Children With Severe CP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- REACH 5Independent statistical analysis of Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant: primary endpoint results, effect estimate with confidence…
- REACTIndependent statistical analysis of Safety and Efficacy of Ranibizumab for Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01982435).
- READY-4Independent statistical analysis of Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Real World Study: Genotype 1 Chronic Hepatitis C Virus Treatment and Evaluation of Real World SVR and PRO: Complete Statistical AnalysisIndependent statistical analysis of Real World Study: Genotype 1 Chronic Hepatitis C Virus Treatment and Evaluation of Real World SVR and PRO: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- REAL-ICUIndependent statistical analysis of Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Real-PD Trial: Development of Clinical Prognostic Models for Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Real-PD Trial: Development of Clinical Prognostic Models for Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02474329).
- Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China: Complete Statistical AnalysisIndependent statistical analysis of Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02668640).
- Reanimation in Tetraplegia: Complete Statistical AnalysisIndependent statistical analysis of Reanimation in Tetraplegia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01997125).
- Rebif® Pregnancy Registry: Complete Statistical AnalysisIndependent statistical analysis of Rebif® Pregnancy Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00338741).
- RECAD-AFIndependent statistical analysis of Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients: Complete Statistical AnalysisIndependent statistical analysis of RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RECIAIndependent statistical analysis of Multifactorial Approach to Emergent Cerclage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01114516).
- Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01928030).
- Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis: Complete Statistical AnalysisIndependent statistical analysis of Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial: Complete Statistical AnalysisIndependent statistical analysis of Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00545181).
- Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease: Complete Statistical AnalysisIndependent statistical analysis of Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- REDEFINEIndependent statistical analysis of Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- REDIRECTIndependent statistical analysis of Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- REDPINEIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19): primary endpoint results, effect…
- Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THS: Complete Statistical AnalysisIndependent statistical analysis of Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission: Complete Statistical AnalysisIndependent statistical analysis of Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission: primary endpoint results, effect estimate with confidence…
- Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease: Complete Statistical AnalysisIndependent statistical analysis of Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease: primary endpoint results, effect…
- Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers: Complete Statistical AnalysisIndependent statistical analysis of Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- REDUCEhfIndependent statistical analysis of Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Reducing Adolescent Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Reducing Adolescent Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04120376).
- Reducing Bacteria That Cause Tooth Decay: Complete Statistical AnalysisIndependent statistical analysis of Reducing Bacteria That Cause Tooth Decay: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03062605).
- Reducing Preterm Births in Underserved Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Reducing Preterm Births in Underserved Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01344616).
- Refitting Somofilcon A Sphere Contact Lens Wearers Into Fanfilcon A Sphere Lenses for 4-Weeks of Wear: Complete Statistical AnalysisIndependent statistical analysis of Refitting Somofilcon A Sphere Contact Lens Wearers Into Fanfilcon A Sphere Lenses for 4-Weeks of Wear: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- REFLEXIONIndependent statistical analysis of Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00813709).
- ReFOCUS1Independent statistical analysis of Reducing Frailty for Older Cancer Survivors Using Supplements: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04553666).
- Regadenoson Real Time Perfusion Imaging Trial-Optison: Complete Statistical AnalysisIndependent statistical analysis of Regadenoson Real Time Perfusion Imaging Trial-Optison: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01489176).
- REGAiN-1AIndependent statistical analysis of Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- REGALEIndependent statistical analysis of T-Reg Cell Kinetics, Stem Cell Transplant, REGALE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00578539).
- REGARD-PGxIndependent statistical analysis of The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- REGENT-1Independent statistical analysis of Safety and Feasibility of a Novel Endoscopic Intervention for the Treatment of Type II Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- REGKINEIndependent statistical analysis of T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00578461).
- Regulatory Request NIS in Korea: Complete Statistical AnalysisIndependent statistical analysis of Regulatory Request NIS in Korea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03642717).
- Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment: Complete Statistical AnalysisIndependent statistical analysis of Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00288886).
- ReITIrateIndependent statistical analysis of Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies: primary endpoint results, effect estimate with confidence interval,…
- Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers – a Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI): Complete Statistical AnalysisIndependent statistical analysis of Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01681589).
- Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Relative Bioavailability of Evobrutinib Tablet Batches: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of Evobrutinib Tablet Batches: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07214922).
- Relative Bioavailability of of Olodaterol and Ketoconazole: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of of Olodaterol and Ketoconazole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01153711).
- Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02572609).
- Relative Bioavailability Study of Emodepside IR-tablets and Solution: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Emodepside IR-tablets and Solution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03383523).
- Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…